openPR Logo
Press release

Enteric Disease Testing Global Market Report 2024 by The Business Research Company | Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science In

Enteric Disease Testing Market Trends

Enteric Disease Testing Market Trends

The enteric disease testing market size has grown strongly in recent years. It will grow from $4.33 billion in 2023 to $4.59 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to water and food safety concerns, increased outbreaks and epidemics, globalization of food supply, increased travel-related infections, regulatory standards.

The enteric disease testing market size is expected to see strong growth in the next few years. It will grow to $5.81 billion in 2028 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to integration of telemedicine and remote monitoring, climate change effects, cross-sector collaboration, antimicrobial resistance, emerging enteric pathogens. Major trends in the forecast period include molecular diagnostics, digital health integration, ai and machine learning, adoption of syndromic testing, point-of-care testing.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp

Enteric Disease Testing Market Major Segments
The enteric disease testing market covered in this report is segmented -

1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types
2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies
3) By Application: Hospitals, Research Centers, Clinics, Other Applications

Key Driver - The Increasing Cases Of Diarrhea And Hemolytic Urea Syndrome (HUS) Driving Growth In The Enteric Disease Testing Market

The increasing cases of diarrhea and hemolytic urea syndrome (HUS) are expected to propel the growth of the enteric disease testing market going forward. The major cause of diarrhea disease cases is the consumption of contaminated food and water. The disorder hemolytic urea syndrome (HUS) affects the blood and blood vessels and is most common in children with diarrhea. Diarrheal disease and HUS are among the leading causes of death in children under five. The increasing cases of diarrhea and hemolytic will need testing solutions, raising the demand for enteric disease testing solutions. For instance, according to the Centers for Disease Control and Prevention, diarrhea is the second greatest cause of mortality among children under the age of 5, 801 thousand worldwide, accounting for one out of every nine child deaths every year. Thus, the increasing incidences of enteric diseases will drive the growth of the enteric disease testing market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=6118&type=smp

Prominent Trend - Companies Opening New Food Testing Laboratories In The Enteric Disease Testing Market

The opening of new laboratories by companies for providing food-testing services is emerging as a key trend in the enteric disease testing market. Major companies operating in the enteric disease testing market are focused on opening new laboratories to provide food testing services. For instance, in June 2021, SGS Group, a Switzerland-based company that provides verification, testing, inspection, and certification services, announced the opening of NATA ISO17025 Accredited Laboratory, the latest addition to the SGS group which offers internationally recognized quality testing to the food manufacturing, retail market, and hospitality segments.

Enteric Disease Testing Market Players
Major companies operating in the enteric disease testing market include Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Quest Consumer Inc., Trinity Biotech plc., Abbott Laboratories, GlaxoSmithKline Plc., Sanofi India Limited., Bayer HealthCare Pharmaceuticals LLC, Fisher Scientific Inc., Bio Rad Laboratories Pvt Ltd., Alere Inc., 3M Company., ALS Limited, Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, Illumina Inc., BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the enteric disease testing market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Enteric Disease Testing Market Report Structure
3. Enteric Disease Testing Market Trends And Strategies
4. Enteric Disease Testing Market - Macro Economic Scenario
5. Enteric Disease Testing Market Size And Growth
…..
27. Enteric Disease Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Enteric Disease Testing Global Market Report 2024 by The Business Research Company | Becton Dickinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science In here

News-ID: 3548097 • Views:

More Releases from the business research company

Global Glycerol Derivatives Market Worth $21.97 Billion by 2029, Growing at 6.5% CAGR
Global Glycerol Derivatives Market Worth $21.97 Billion by 2029, Growing at 6.5% …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Glycerol Derivatives Market Outlook: What Size And CAGR Are Anticipated By 2025? The market size of glycerol derivatives has seen robust growth in the past few years. The scale is expected to expand from $16.11 billion in 2024 to $17.1 billion in 2025, registering a compound annual growth rate (CAGR)
Fructooligosaccharides Industry Set to Achieve $4.25 Billion Milestone by 2029 | Steady 7.7% CAGR
Fructooligosaccharides Industry Set to Achieve $4.25 Billion Milestone by 2029 | …
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments. What Is the Long-Term Growth Forecast for the Fructooligosaccharides Market Size 2025? The market size of fructooligosaccharides has been experiencing a robust expansion in the past few years. The value is predicted to escalate from $2.95 billion in 2024 to $3.17 billion in 2025, with a compound annual growth rate (CAGR) of
Global Ethyl Tertiary-butyl Ether Market Size, Share, and Forecast Analysis 2025-2029
Global Ethyl Tertiary-butyl Ether Market Size, Share, and Forecast Analysis 2025 …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. What Are the Ethyl Tertiary-butyl Ether Market Size Forecast for 2025? In recent times, the market size of ethyl tertiary-butyl ether has experienced robust growth. Expectations foresee the market expanding from $5.91 billion in 2024 to $6.35 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. The
Global Proof Paint Market Worth $186.15 Billion by 2029, Growing at 7.7% CAGR
Global Proof Paint Market Worth $186.15 Billion by 2029, Growing at 7.7% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide. Proof Paint Market Outlook: What Size And CAGR Are Anticipated By 2025? The market size for -resistant paint has significantly expanded in the past few years. An increase from $128.77 billion in 2024 to $138.53 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 7.6%.

All 5 Releases


More Releases for Disease

Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research. Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight: Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and